Viatris, Inc. has recalled one lot of Xanax XR (alprazolam) extended-release 3 mg tablets due to a failure to meet dissolution specifications. These tablets are designed to release medication slowly over time, and a failure in dissolution means the medication may not be released at the intended rate, potentially impacting its effectiveness. No incidents or injuries have been reported to date in connection with this issue.
The product failed dissolution testing, which means the extended-release mechanism may not function correctly. This could lead to the medication being released too quickly or too slowly, potentially resulting in sub-therapeutic levels or an unexpected dose of alprazolam.
You have 2 options:
Distributed by Viatris Specialty LLC, Morgantown, WV 06506
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.